PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
J Neurovirol. Author manuscript; available in PMC 2010 June 9.
Published in final edited form as:
PMCID: PMC2882804
NIHMSID: NIHMS209416

Theiler's murine encephalomyelitis virus attachment to the gastrointestinal tract is associated with sialic acid binding

Abstract

DA and GDVII are strains of Theiler's murine encephalomyelitis virus (TMEV). DA virus mutant DApB encodes VP2 puff B of GDVII, whereas DApBL2M contains VP1 loop II of GDVII with a point mutation in VP2 puff B. Neuraminidase treatment of cells inhibited infection by DA and DApB, but not GDVII or DApBL2M viruses; sialic acid (SA) binding correlated with virus persistence. In virus binding assays to intestine sections, all four TMEVs bound goblet cells and the mucus of the epithelium that was SA dependent. Therefore, differences in SA composition on different cell types can affect tropism and infection.

Keywords: CNS autoimmune demyelinating diseases, multiple sclerosis, intestinal mucosa, mucins, N-acetylneuraminic acid, virus receptors

Several viruses, including paramyxoviruses and coronaviruses, have the ability to bind sialic acid (SA) in vitro (Compans and Herrler, 2005). Although its role in pathogenesis in vivo remains largely unknown, SA-binding has been associated with the ability to cause disease (Helander et al, 2003; Barton et al, 2003; Forrest and Dermody, 2003; Komagome et al, 2002; Liu et al, 1998). For example, influenza viruses attach to cells by the viral hemagglutinin binding to sialosaccharides (van Riel et al, 2006). The porcine coronavirus, transmissible gastroenteritis virus (TGEV), which is a cause of a fatal diarrhea in newborn piglets, agglutinates erythrocytes in vitro due to SA-binding activity (Krempl et al, 1997). TGEV containing mutations within the S glycoprotein loses hemagglutinating activity and has reduced enteropathogenicity. Wild-type TGEV binds more efficiently to cells than viral mutants lacking SA-binding activity (Schwegmann-Weßels et al, 2002). Similarly, reovirus type 1 Lang (T1L) binds selectively to M cells with glycoconjugates containing SA in the intestinal epithelium (Helander et al, 2003; Barton et al, 2003; Forrest and Dermody, 2003; Komagome et al, 2002; Liu et al, 1998).

Picornaviruses are positive-strand RNA viruses, and cause infection of the enteric and respiratory systems. In natural picornavirus infection in humans, viruses are able to spread from the gut to the central nervous system (CNS), causing meningitis and encephalitis (Melnick, 1996). However, how these viruses disseminate is not well studied. Theiler's murine encephalomyelitis virus (TMEV) belongs to the family Picornaviridae (Roos, 2002; Tsunoda and Fujinami, 1996, 1999; Tsunoda and Fujinami). TMEV is divided into two subgroups: GDVII and TO, based upon neurovirulence. In nature, TMEV transmission occurs by the fecal-oral route, resulting in an unapparent infection of the gut (Lipton et al, 2006); however, on occasion, TMEV is able to infect the CNS (Theiler, 1934). We do not know how TMEV infects in the gut and spread into the CNS, although enteric TMEV infection can be a good model system to study how enteric virus disseminates into the CNS in humans.

Experimentally, intracerebral (i.c.) GDVII virus infection of mice causes an acute fatal encephalitis, whereas i.c. infection with the TO subgroup, including Daniels (DA) and BeAn viruses, results in a chronic inflammatory demyelinating disease in the CNS (Villarreal et al, 2006). TMEV encodes four capsid proteins: VP1 to VP4, and has unique loop structures that are made up of connections of the β strand. There are four large loops between the CD strands of VP1 (loops I and II) and the EF strands of VP2 (puffs A and B). Exposed amino acids on all four loops have been shown to be important disease determinants (McCright et al, 1999, 2002; McCright et al.; Tsunoda et al, 2001; Wada et al, 1998). Several differences between the TO and GDVII subgroups are located in VP1 loop II and VP2 puff B. These two surface features are located spatially near each other, close to the proposed receptor binding site, “pit,” or depression surrounding the fivefold axis of TMEV (Grant et al, 1992; Luo et al, 1996; McCright et al, 1999; Tsunoda et al, 2001).

Although the two subgroups of TMEV may share a common receptor (Fotiadis et al, 1991), the TO subgroup binds α2,3 SA moieties on N-linked oligosaccharides at the surface of susceptible cells (Fotiadis et al, 1991; Shah and Lipton, 2002; Zhou et al, 1997, 2000; Zhou et al.). However, the attachment to N-linked oligosaccharides accounts for only a portion of GDVII virus binding (Shah and Lipton, 2002; Lipton et al, 2006). Atomic modeling of DA virus complexed with sialyllactose was consistent with SA-binding to a positively charged pocket, termed “gap,” on the capsid surface (Zhou et al, 2000). The gap is formed by the interaction between VP1 loop II and VP2 puff B and is shaped differently between GDVII and TO subgroups (Zhou et al, 1997). SA has been suggested to interact directly with VP2 puff B: VP2-161, -163, and -174 of DA virus (Zhou et al, 2000) and VP2-161 and -174 of BeAn virus (Kumar et al, 2003). Amino acids comprising VP1 loop II likely influence SA- binding, although they have no direct interactions with SA residues. GDVII virus has been shown to use the proteoglycan heparin sulfate, but not SA, as a coreceptor (Shah and Lipton, 2002; Lipton et al, 2006). Although it is not clear how differences in SA-binding between GDVII versus TO subgroups contribute to differing biological activities in vivo, the requirement of virus binding to SA on cells could contribute to the different pattern of disease observed between TO versus GDVII virus infection.

Previously, we reported neuropathology caused by two DA mutant viruses: DApB and DApBL2M (Tsunoda et al, 2001, 2007; Tsunoda et al.). DApB virus encodes the VP2 puff B of GDVII virus with one conservative change from GDVII virus (A173V). DApBL2M virus contains the VP1 loop II of GDVII virus and has a point mutation (S171R) in VP2 puff B. Both mutant viruses are on the background of DA virus. Although all viruses replicated to similar titers in vitro, i.c. infection of mice with GDVII, DA, DApB, and DApBL2M viruses resulted in distinct CNS pathology. During the acute stage, mice infected with GDVII virus had large numbers of apoptotic neurons with a relative lack of T-cell infiltration in the brain and all infected mice died (Tsunoda et al, 2007). Similarly, the two DA virus mutants induced higher levels of apoptosis in neurons than wild-type DA virus, although levels of inflammation were similar between DA and DA virus mutants (Tsunoda et al, 2007). During the chronic stage, DA and DApB induced demyelinating disease with virus persistence in the white matter of the spinal cord, whereas DApBL2M caused gray matter lesions in the brain without demyelination (Tsunoda et al, 2001). These data suggest that conformational differences via interaction of VP1 loop II and VP2 puff B between GDVII and DA viruses play an important role in TMEV disease.

We first tested the contribution of VP1 loop II and VP2 puff B in SA-binding in vitro and correlated this with virus replication. TMEV has been shown to cause cytopathic effects (CPEs), but not apoptosis, in permissive baby hamster kidney (BHK)-21 cells, whereas TMEV causes apoptosis with no or limited CPEs in restrictive cells (Jelachich and Lipton, 1996). BHK-21 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS). Binding of TMEV to SA was tested using treatment with neuraminidase (sialidase) to remove cell surface SA prior to virus adsorption/infection (Fotiadis et al, 1991; Jnaoui et al, 2002). BHK-21 cell monolayers grown in 24-well plates were washed with serum-free DMEM at pH 5.5 and then incubated for 1 h at 37°C, pH 5.5 with α2-3,6,8-neuraminidase (Vibrio cholerae sialidase, Calbiochem) at 20 and 200 mU/ml. Cells were washed and infected with TMEV at a multiplicity of infection (MOI) of 3. After a 1-h virus adsorption, cells were washed and cultured in DMEM containing 2% FBS. CPEs were monitored for 24 h.

Neuraminidase treatment inhibited CPEs of BHK-21 cells induced by DA virus, whereas treatment had no effect on GDVII virus infection (Figure 1). Interestingly, reduced CPEs by neuraminidase treatment was also seen in DApB virus infection, but not in DApBL2M virus infection. Virus titers were also compared in TMEV-infected cell cultures, with or without SA digestion by neuraminidase, after one replication cycle. At 8 and 24 h post infection (p.i.), infected cells and supernatant fluids were collected, and viral titers were determined by plaque assay (McCright et al, 1999). Neuraminidase treatment prior to DA and DApB virus infection reduced virus titers by more than 90%, versus mock treated control cultures at 8 h p.i. (Figure 2a). A dose-dependent reduction of virus titers by neuraminidase treatment was also seen in DA and DApB virus infection at 24 h p.i. (Figure 2b). In contrast, in GDVII or DApBL2M virus infections, no significant reductions in virus titer by neuraminidase treatment were observed at 8 or 24 h p.i. These results are compatible with previous findings where CPE of BHK-21 cells was reduced in BeAn and DA, but not in GDVII, virus infections by addition of sialyllactose, the first three sugar molecules of common oligosaccharides on the surface of mammalian cells (Fotiadis et al, 1991; Shah and Lipton, 2002; Zhou et al, 1997, 2000), In those experiments, the reduction in the ability of TMEV to infect cells was associated with SA-dependent virus attachment to BHK-21 cells. Therefore, our results predict that VP1 loop II and VP2 puff B influence the requirement for viral attachment to SA on cells. However, it should be noted that, even after high doses of neuraminidase treatment, a substantial amount of virus replication was detected in all TMEV infections; blocking of SA binding did not completely abrogate virus infection/attachment.

Figure 1
Influence of neuraminidase treatment on cytopathic effects (CPEs) by TMEV infection. At 24 h p.i., neuraminidase treatment (right panels) did not inhibit CPEs in cultures infected with GDVII virus, but did inhibit CPEs in cultures infected with DA virus, ...
Figure 2
Effect of neuraminidase treatment on virus replication. Virus titers were determined in TMEV-infected cultures with or without 20 or 200 mU/ml of neuraminidase at 8 (a) or 24 (b) h p.i. Neuraminidase treatment reduced the virus titers in DA and DApB virus ...

Although TMEV has been isolated from the gastrointestinal tract, the cell types in the intestine that the virus binds are unknown (Theiler, 1941). Therefore, we analyzed the binding of TMEV to murine intestinal epithelium, the natural target for this virus, using virus overlay assays, which have been widely used to test tissue attachment of microbes, such as Helicobacter pylori and influenza virus H5N1 (Falk et al, 1993; van Riel et al, 2006; Helander et al, 2003) (Figure 3). We harvested the intestine from naïve mice without washing the intestine. We fixed the intestine in 4% paraformaldehyde, embedded in paraffin, and made 4-μm paraffin sections. Intestine sections were deparaffinized, washed three times with phosphate-buffered saline (PBS), blocked with PBS containing 3% normal donkey serum for 30 min, and incubated with DMEM containing DA, GDVII, DapB, or DApBL2M virus, at a final concentration of 1 × 109 plaque-forming units (PFU)/ml for 1 h. Sections were incubated with antibody against TMEV (Tsunoda et al, 2001), followed by secondary tetramethyl rhodamine isothiocyanate (TRITC) conjugated anti-rabbit immunoglobulin G (IgG).

Figure 3
Intestine section preparation and a virus overlay assay. Intestinal epithelium is composed of enterocytes, goblet cells, Paneth cells, and M cells. The intestinal lymphocytes disseminate beneath the epithelium and also between epithelial cells. Lymphocytes ...

All four TMEVs showed a similar pattern of attachment to the intestine (Figure 4a to d). Virus was associated with the mucus at the surface of the intestine and bound to goblet cells. Goblet cells are specialized epithelial cells that synthesize and secrete mucins. This suggests that virus attached to the mucus produced by goblet cells. Virus binding to Peyer's patches was similar; virus was found at the surface of epithelia and in the cell bodies of goblet cells (Figure 4e). Virus was also seen bound to cells in the crypt of the intestine (Figure 4f). We did not see autofluorescence in the intestine sections (Figure 5b) nor positive staining in negative controls, such as incubation with TMEV antibody and secondary antibody without virus overlay (Figure 5d), incubation with secondary antibody alone, and incubation with normal rabbit serum instead of TMEV antibody. The identification of goblet cells was confirmed by periodic–acid Schiff (PAS) staining where mucins stain purple-magenta (Figure 4g, h). The presence of mucins on the intestine sections were confirmed on the luminal surface of the intestinal villi as well as in the cytoplasm of goblet cells (Figure 4h).

Figure 4
(a–f) Virus overlay assays. Intestine sections were incubated with DA (a, f), GDVII (b), DApB (c), or DApBL2M (d, e) virus, followed by rabbit antibody against TMEV and TRITC-conjugated anti-rabbit IgG. (a–d) Transverse sections showed ...
Figure 5
Effect of neuraminidase treatment on virus binding. (a–c) Intestine sections were incubated with DA virus. Virus binding (red) was visualized with rabbit antibody against TMEV, followed by incubation with TRITC-conjugated anti-rabbit IgG. The ...

Because all four TMEVs showed similar binding to the intestinal tissue, this suggested that all four TMEVs use a similar receptor/co-receptor. To test whether virus attachment depended on SA-binding, prior to incubation with TMEV, tissue sections were incubated in serum-free DMEM containing neuraminidase at 20 mU/ml at pH 5.5 for 1 h at 37°C. In contrast to virus attachment on BHK-21 cells, the binding of all four TMEVs was significantly diminished (Figure 5). These results indicate that all four TMEVs attach to mucin-producing goblet cells in a SA-dependent fashion. In neuraminidase-treated sections, we sometimes detected faint residual virus binding to cells, presumably Paneth cells, near the crypt in all four TMEVs for unknown reasons (Figure 5c, f). However, because the area is not on the surface of the intestine, it is unlikely that TMEV uses these cells for entry during enteric infection.

We do not know the physiologic role of SA-binding by TMEV in the intestine. Goblet cell binding by virus via SA was shown in TGEV infection (Schwegmann-Weßels et al, 2003). As was suggested in TGEV infection (Schultze et al, 1996), binding of sialylated macromolecules may increase the stability of virions and thus facilitate survival in the gastrointestinal tract, protecting the virus from inactivation due to low pH and proteases (Krempl et al, 2000; Lipton et al, 2005). Virus binding to mucin via SA may also allow the virus to remain longer in the intestine. This would make it easier to interact with the cellular receptor initiating intestinal infection, thus preventing the loss of virions due to intestinal peristalsis (Schwegmann-Weßels et al, 2003). In addition, because VP1 loop II and VP2 puff B of TMEV contain antibody binding sites (Tsunoda and Fujinami, 2007), SA-binding of virus may also prevent TMEV from neutralization by antibody against TMEV in the gastrointestinal tract.

In contrast, mucus is known to act as a barrier in the mucosal immune system. It regulates mucosal microbiota by secreted antibodies and mucus (Cone, 2005). To infect the intestinal epithelium, virions must pass through the mucus blanket and glycocalyx on the gastrointestinal epithelium to reach cellular receptors on the apical surface of the epithelial cells (Schwegmann-Weßels et al, 2003). Microorganisms, including viruses, are known to be trapped by mucus. In the mucus, aggulutination and neutralization by antibodies, especially polyvalent IgA and IgM, can occur. Mucin, the primary component of the mucus layer, can also inhibit SA-dependent virus-cell attachment, resulting in suppression of virus infection (Chen et al, 1993).

Currently, we cannot explain why GDVII and DApBL2M viruses have differences in SA dependency for attachment to BHK-21 cells versus intestine tissues. Interestingly, wheat germ aggulutinin (WGA), which specifically binds to SA residues, reduces the BHK-21 cell binding of both BeAn and GDVII viruses in vitro, although neuraminidase treatment has no effect on GDVII virus binding to BHK-21 cells (Fotiadis et al, 1991; Kilpatrick and Lipton, 1991). However, our studies using intestinal tissue as substrate in binding assays should be more relevant to what is occurring in vivo.

The requirement for SA in viral attachment could also be different between the gastrointestinal tract versus the CNS. Jnaoui et al (2002) hypothesized that VP1 loop II and VP2 puff B of TMEV contact the carbohydrate moiety of the receptor, thus altering TMEV tropism and pathogenicity. They demonstrated decreased ability by two DA virus mutants, KJ6 virus with mutations in VP1 loop II and VP2 puff B and OT11 virus with mutations in VP1 loop II, to persist in the CNS. Sialyllactose inhibition studies found decreased SA usage for entry by KJ6 virus. In addition, mice infected for 6 days with GDVII virus mutant KJ38, which has three mutations in VP2 puff B and two in VP1 (VP1-51 and -195), had a dramatic decrease in the number of infected cells in the CNS compared to mice infected with wild-type GDVII virus. Sialidase treatment of cells in vitro reduced infection by KJ38 virus, indicating binding of KJ38 virus to SA.

In summary, we demonstrated that DApBL2M virus, which has mutations in both VP1 loop II and VP2 puff B, showed decreased SA-binding similar to that of GDVII virus. Our results support the hypothesis that VP1 loop II and VP2 puff B form the SA-binding site, termed “gap.” Virus overlay assays indicated that not only DA and DApB but also GDVII and DApBL2M viruses bound to mucus, which is produced in the cell bodies of goblet cells and spreads onto the surface of epithelium, in the intestine. This attachment was dependent upon the presence of SA. Our report is the first to show that the requirement for SA in viral attachment is different among host cell types and this could lead to differences in cell tropism and disease.

Acknowledgments

This work was supported by NIH grant R01NS034497. The authors thank Eiji Morita, PhD, for helpful discussions, and Nancy K. Burgess, BS, Sarah E. Doyle, BS, Nikki J. Kirkman, BS, Mikako Kobayashi-Warren, MD, Faris Hasanovic, Andy Luu, and Emily Jane Terry for technical assistance, and Ms. Kathleen Borick for manuscript preparation.

Footnotes

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

References

  • Barton ES, Youree BE, Ebert DH, Forrest JC, Connolly JL, Valyi-Nagy T, Washington K, Wetzel JD, Dermody TS. Utilization of sialic acid as a coreceptor is required for reovirus-induced biliary disease. J Clin Invest. 2003;111:1823–1833. [PMC free article] [PubMed]
  • Chen CC, Baylor M, Bass DM. Murine intestinal mucins inhibit rotavirus infection. Gastroenterology. 1993;105:84–92. [PubMed]
  • Compans RW, Herrler G. Virus infection of epithelial cells. In: Mestecky J, Bienestock J, Lamm ME, Mayer L, McGhee JR, Strober W, editors. Mucosal immunology. 3rd ed Elsevier Academic Press; Burlington, MA: 2005. pp. 769–782.
  • Cone RA. Mucus. In: Mestecky J, Bienestock J, Lamm ME, Mayer L, McGhee JR, Strober W, editors. Mucosal immunology. 3rd ed Elsevier Academic Press; Burlington, MA: 2005. pp. 49–72.
  • Falk P, Roth KA, Borén T, Westblom TU, Gordon JI, Normark S. An in vitro adherence assay reveals that Helicobacter pylori exhibits cell lineage-specific tropism in the human gastric epithelium. Proc Natl Acad Sci USA. 1993;90:2035–2039. [PubMed]
  • Forrest JC, Dermody TS. Reovirus receptors and pathogenesis. J Virol. 2003;77:9109–9115. [PMC free article] [PubMed]
  • Fotiadis C, Kilpatrick DR, Lipton HL. Comparison of the binding characteristics to BHK-21 cells of viruses representing the two Theiler's virus neurovirulence groups. Virology. 1991;182:365–370. [PubMed]
  • Grant RA, Filman DJ, Fujinami RS, Icenogle JP, Hogle JM. Three-dimensional structure of Theiler virus. Proc Natl Acad Sci U S A. 1992;89:2061–2065. [PubMed]
  • Helander A, Silvey KJ, Mantis NJ, Hutchings AB, Chandran K, Lucas WT, Nibert ML, Neutra MR. The viral σ1 protein and glycoconjugates containing α2-3-linked sialic acid are involved in type 1 reovirus adherence to M cell apical surfaces. J Virol. 2003;77:7964–7977. [PMC free article] [PubMed]
  • Jelachich ML, Lipton HL. Theiler's murine encephalomyelitis virus kills restrictive but not permissive cells by apoptosis. J Virol. 1996;70:6856–6861. [PMC free article] [PubMed]
  • Jnaoui K, Minet M, Michiels T. Mutations that affect the tropism of DA and GDVII strains of Theiler's virus in vitro influence sialic acid binding and pathogenicity. J Virol. 2002;76:8138–8147. [PMC free article] [PubMed]
  • Kilpatrick DR, Lipton HL. Predominant binding of Theiler's viruses to a 34-kilodalton receptor protein on susceptible cell lines. J Virol. 1991;65:5244–5249. [PMC free article] [PubMed]
  • Komagome R, Sawa H, Suzuki T, Suzuki Y, Tanaka S, Atwood WJ, Nagashima K. Oligosaccharides as receptors for JC virus. J Virol. 2002;76:12992–13000. [PMC free article] [PubMed]
  • Krempl C, Ballesteros ML, Zimmer G, Enjuanes L, Klenk HD, Herrler G. Characterization of the sialic acid binding activity of transmissible gastroenteritis coronavirus by analysis of haemagglutination-deficient mutants. J Gen Virol. 2000;81:489–496. [PubMed]
  • Krempl C, Schultze B, Laude H, Herrler G. Point mutations in the S protein connect the sialic acid binding activity with the enteropathogenicity of transmissible gastroenteritis coronavirus. J Virol. 1997;71:3285–3287. [PMC free article] [PubMed]
  • Kumar ASM, Kallio P, Luo M, Lipton HL. Amino acid substitutions in VP2 residues contacting sialic acid in low-neurovirulence BeAn virus dramatically reduce viral binding and spread of infection. J Virol. 2003;77:2709–2716. [PMC free article] [PubMed]
  • Lipton HL, Kumar ASM, Hertzler S, Reddi HV. Differential usage of carbohydrate co-receptors influences cellular tropism of Theiler's murine encephalomyelitis virus infection of the central nervous system. Glycoconj J. 2006;23:39–49. [PubMed]
  • Lipton HL, Kumar ASM, Trottier M. Theiler's virus persistence in the central nervous system of mice is associated with continuous viral replication and a difference in outcome of infection of infiltrating macrophages versus oligodendrocytes. Virus Res. 2005;111:214–223. [PubMed]
  • Liu CK, Wei G, Atwood WJ. Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal α(2 6)-linked sialic acids. J Virol. 1998;72:4643–4649. [PMC free article] [PubMed]
  • Luo M, Toth KS, Zhou L, Pritchard A, Lipton HL. The structure of a highly virulent Theiler's murine encephalomyelitis virus (GDVII) and implications for determinants of viral persistence. Virology. 1996;220:246–250. [PubMed]
  • McCright IJ, Tsunoda I, Libbey JE, Fujinami RS. Mutation in loop I of VP1 of Theiler's virus delays viral RNA release into cells and enhances antibody-mediated neutralization: A mechanism for the failure of persistence by the mutant virus. J Neuro Virol. 2002;8:100–110. [PubMed]
  • McCright IJ, Tsunoda I, Whitby FG, Fujinami RS. Theiler's viruses with mutations in loop I of VP1 lead to altered tropism and pathogenesis. J Virol. 1999;73:2814–2824. [PMC free article] [PubMed]
  • Melnick JL. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In: Fields BN, Knipe DM, Howley PM, Chanock RM, Melnick JL, Monath TP, Roizman B, Straus SE, editors. Fields virology. 3rd ed Raven Publishers; Philadelphia: 1996. pp. 655–712.
  • Roos RP. Pathogenesis of Theiler's murine encephalomyelitis virus-induced disease. In: Semler BL, Wimmer E, editors. Molecular biology of picornaviruses. ASM Press; Washington DC: 2002. pp. 427–435.
  • Schultze B, Krempl C, Ballesteros ML, Shaw L, Schauer R, Enjuanes L, Herrler G. Transmissible gastroenteritis coronavirus, but not the related porcine respiratory coronavirus, has a sialic acid (N-glycolylneuraminic acid) binding activity. J Virol. 1996;70:5634–5637. [PMC free article] [PubMed]
  • Schwegmann-Webels C, Zimmer G, Laude H, Enjuanes L, Herrler G. Binding of transmissible gastroenteritis coronavirus to cell surface sialoglycoproteins. J Virol. 2002;76:6037–6043. [PMC free article] [PubMed]
  • Schwegmann-Weßels C, Zimmer G, Schroder B, Breves G, Herrler G. Binding of transmissible gastroenteritis coronavirus to brush border membrane sialoglyco-proteins. J Virol. 2003;77:11846–11848. [PMC free article] [PubMed]
  • Shah AH, Lipton HL. Low-neurovirulence Theiler's viruses use sialic acid moieties on N-linked oligosaccharide structures for attachment. Virology. 2002;304:443–450. [PubMed]
  • Theiler M. Spontaneous encephalomyelitis of mice—a new virus disease. Science. 1934;80:122. [PubMed]
  • Theiler M. Studies on poliomyelitis. Medicine. 1941;20:443–462.
  • Tsunoda I, Fujinami RS. Two models for multiple sclerosis: Experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J Neuropathol Exp Neurol. 1996;55:673–686. [PubMed]
  • Tsunoda I, Fujinami RS. Theiler's murine encephalomyelitis virus. In: Ahmed R, Chen ISY, editors. Persistent viral infections. John Wiley & Sons; Chichester: 1999. pp. 517–536.
  • Tsunoda I, Fujinami RS. Neuropathogenesis of Theiler's murine encephalomyelitis virus infection. In: Zhang X, editor. Encyclopedia of Bioscience, “RNA viruses and CNS diseases: Mechanisms pathogenesis and persistence.”. Frontiers in Bioscience; 2008. http://www.bioscience.org, in press.
  • Tsunoda I, Libbey JE, Fujinami RS. TGF-β1 suppresses T cell infiltration and VP2 puff B mutation enhances apoptosis in acute polioencephalitis induced by Theiler's virus. J Neuroimmunol. 2007;190:80–89. [PMC free article] [PubMed]
  • Tsunoda I, Wada Y, Libbey JE, Cannon TS, Whitby FG, Fujinami RS. Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B. J Virol. 2001;75:7494–7505. [PMC free article] [PubMed]
  • van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RAM, Osterhaus ADME, Kuiken T. H5N1 virus attachment to lower respiratory tract. Science. 2006;312:399. [PubMed]
  • Villarreal D, Young CR, Storts R, Ting JW, Welsh CJR. A comparison of the neurotropism of Theiler's virus and poliovirus in CBA mice. Microb Pathog. 2006;41:149–156. [PubMed]
  • Wada Y, McCright IJ, Whitby FG, Tsunoda I, Fujinami RS. Replacement of loop II of VP1 of the DA strain with loop II of the GDVII strain of Theiler's murine encephalomyelitis virus alters neurovirulence, viral persistence, and demyelination. J Virol. 1998;72:7557–7562. [PMC free article] [PubMed]
  • Zhou L, Lin X, Green TJ, Lipton HL, Luo M. Role of sialyloligosaccharide binding in Theiler's virus persistence. J Virol. 1997;71:9701–9712. [PMC free article] [PubMed]
  • Zhou L, Luo Y, Wu Y, Tsao J, Luo M. Sialylation of the host receptor may modulate entry of demyelinating persistent Theiler's virus. J Virol. 2000;74:1477–1485. [PMC free article] [PubMed]